Final answer:
ASO is an experimental treatment that shows promise in treating Huntington's disease by targeting the genetic cause of the disease.
Step-by-step explanation:
Huntington's disease is a progressive neurological disorder that is caused by a dominant allele. While there is no cure for Huntington's disease, an experimental treatment called Antisense Oligonucleotide Therapy (ASO) has shown promising results in clinical trials. ASO works by targeting the underlying genetic cause of Huntington's disease and reducing the production of the toxic protein responsible for the disease. However, it's important to note that ASO is still in the experimental stage and its availability and effectiveness may vary for different patients.